Söndag 9 Mars | 15:38:23 Europe / Stockholm

Kalender

Est. tid*
2026-02-11 10:30 Bokslutskommuniké 2025
2025-11-12 08:30 Kvartalsrapport 2025-Q3
2025-08-27 08:30 Kvartalsrapport 2025-Q2
2025-05-30 N/A X-dag ordinarie utdelning QLIFE 0.00 SEK
2025-05-28 N/A Årsstämma
2025-05-07 08:30 Kvartalsrapport 2025-Q1
2025-03-21 N/A Extra Bolagsstämma 2025
2025-02-12 - Bokslutskommuniké 2024
2024-11-07 - Kvartalsrapport 2024-Q3
2024-08-29 - Kvartalsrapport 2024-Q2
2024-07-30 - Split QLIFE 2000:1
2024-05-28 - Kvartalsrapport 2024-Q1
2024-05-08 - X-dag ordinarie utdelning QLIFE 0.00 SEK
2024-05-07 - Årsstämma
2024-02-08 - Bokslutskommuniké 2023
2024-01-16 - Extra Bolagsstämma 2023
2023-11-13 - Kvartalsrapport 2023-Q3
2023-08-17 - Kvartalsrapport 2023-Q2
2023-05-26 - Kvartalsrapport 2023-Q1
2023-05-05 - X-dag ordinarie utdelning QLIFE 0.00 SEK
2023-05-04 - Årsstämma
2023-03-24 - Extra Bolagsstämma 2022
2023-02-16 - Bokslutskommuniké 2022
2022-11-25 - Kvartalsrapport 2022-Q3
2022-08-29 - Kvartalsrapport 2022-Q2
2022-05-06 - X-dag ordinarie utdelning QLIFE 0.00 SEK
2022-05-05 - Årsstämma
2022-05-05 - Kvartalsrapport 2022-Q1
2022-02-17 - Bokslutskommuniké 2021
2021-11-08 - Kvartalsrapport 2021-Q3
2021-08-16 - Kvartalsrapport 2021-Q2
2021-05-06 - X-dag ordinarie utdelning QLIFE 0.00 SEK
2021-05-05 - Årsstämma
2021-05-05 - Kvartalsrapport 2021-Q1
2021-02-18 - Bokslutskommuniké 2020
2020-11-19 - Extra Bolagsstämma 2020
2020-11-18 - Kvartalsrapport 2020-Q3
2020-08-18 - Kvartalsrapport 2020-Q2
2020-05-22 - X-dag ordinarie utdelning QLIFE 0.00 SEK
2020-05-20 - Årsstämma
2020-05-20 - Kvartalsrapport 2020-Q1

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Qlife Holding är verksamt inom medicinteknik. Bolaget är specialiserat inom forskning och utveckling av IVD-enheter. Enheterna används som biomarkörstester i blod och används som komplement till övriga tester inom vården. Samarbete utförs även med övriga aktörer på marknaden. Störst verksamhet återfinns inom den nordiska marknaden, med huvudkontoret i Helsingborg.
2025-02-12 08:00:00

Qlife Holding AB (publ) ("Qlife" or the "Company") announces that members of the Company's Board of Directors and management, including CEO Thomas Warthoe, via company, and Chairman of the Board Lars Bangsgaard, via company, has notified their non-binding intention to subscribe for shares with subscription rights in the ongoing rights issue, which was resolved by the Board of Directors on 29 January 2025, and is covered by guarantee commitments amounting to 75.9 percent (the "Rights Issue"). In addition, Lars Bangsgaard is also participating in the top-down-guarantee that was provided free of charge in connection with the announcement of the Rights Issue, as previously communicated.

The non-binding intention from the Board of Directors and management amounts to approximately 1.2 MSEK. In addition, Lars Bangsgaard is also participating in the top-down-guarantee that was provided free of charge in connection with the announcement of the Rights Issue, as previously communicated.

Qlife would like to remind shareholders that the subscription period for the Rights Issue has been open since 11 February 2025. Custody account holders with Nordnet and Avanza can apply to subscribe for shares with or without subscription rights via their respective online services until 24 February 2025, at 23:59. The final day to subscribe for shares with or without subscription rights via Eminova Fondkommission is Tuesday, 25 February 2025, at 15:00. More information on the application process via Nordnet, Avanza, and Eminova Fondkommission is available at www.nordnet.se, www.avanza.se, and www.eminova.se. The information memorandum, containing the full terms and instructions, along with direct links to subscribe for shares, is available on the Company's website at www.qlifeholding.com.

For more information please contact: 

Thomas Warthoe

Chief Executive Officer (CEO)

Phn: +45 21 63 35 34

E-mail: tw@egoo.health

This information was provided by the contact person above for publication on "This placeholder will be replaced with the correct date and send time">2025-02-12 08:00 CET.